Olfactory Disorders
📧 Sign up to get email alerts when something new happens for Olfactory Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: The Relationship Between Olfactory and Gustatory Senses, Hedonic Hunger, and Diet Quality After Bariatric Surgery
A completed clinical trial investigating the relationships between smell and taste, hedonic hunger, and diet quality after bariatric surgery…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: REEDUCATION OF OLFACTORY DISORDERS AFTER A CEREBRAL VASCULAR ACCIDENT IN ADULTS [NA]
An investigation into reeducation of olfactory disorders following an adult stroke, with the trial currently terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
A completed clinical trial assessing olfactory dysfunction in COVID-19 patients, focusing on loss of smell and related quality-of-life impac…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Olfactory Biopsies [NA]
Clinical trial update indicating recruiting status for a study on olfactory biopsies in Alzheimer's disease and smell disorders.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Olfactory Training on Smell Dysfunction Patients in HK [NA]
A Hong Kong clinical trial is evaluating olfactory training for people with smell disorders, sponsored by Pamela Youde Nethersole Eastern Ho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: COVID-19: Post-covid Olfactory Disorders Assessment
A completed clinical trial assessing post-COVID olfactory disorders (loss of smell).
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction [Phase 2]
Phase 2 clinical trial evaluating gabapentin for post-COVID-19 olfactory dysfunction has completed and results have been posted.
-
CLINICAL_TRIALS other · 2025-02-20Clinical Trial Update: Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction [Phase 2]
Phase 2 clinical trial evaluating sodium citrate for smell retraining in people with post-COVID-19 olfactory dysfunction; the study is curre…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis [Phase 4]
Phase 4 study evaluating the effects of dupilumab on sense of smell in nasal polyposis; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Study of EEG and Nasal Stimulus in Olfactory Disorders [NA]
This clinical trial update describes a study evaluating EEG and nasal stimulation for olfactory disorders, currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: GnRH Therapy on Cognition in Down Syndrome [Phase 2, Phase 3]
A Phase 2/3 clinical trial investigating GnRH therapy for cognitive decline in individuals with Down syndrome is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-09Clinical Trial Update: Helping Olfaction and Nutrition On Renal Replacement [Phase 2]
Phase 2 trial update for a study on improving sense of smell and nutrition in patients with renal failure.
-
CLINICAL_TRIALS withdrawal · 2017-06-26Clinical Trial Update: Taste And Smell TEsting in End Stage Renal Disease
The clinical trial NCT03043144 evaluating taste and smell testing in end-stage renal disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-06Clinical Trial Update: Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery [Phase 2]
Phase 2 trial investigating directed high-dose nasal corticosteroids for residual smell loss after sinus surgery was withdrawn.
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study [Phase 2]
This phase 2 pilot study evaluates delta-9-tetrahydrocannabinol (Dronabinol) as an orexigenic therapy to improve appetite in advanced cancer…